Changes of the hepatic proteome in hepatitis B-Lnfected mouse model at early stages of fibrosis

Journal of Proteome Research

Volumn 7, Issue 7, 2008, Pages 2642-2653

  Spano, Daniela ^a   Cimmino, Flora ^a   Capasso, Mario ^a   D'Angelo, Fulvio ^a   Zambrano, Nicola ^a,b   Terracciano, Luigi ^c,d   Iolascon, Achille ^a,b  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

2D DIGE; HBV; Liver fibrosis; Protein expression profile; Transgenic animal

Indexed keywords

ACTIN; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ARGINASE 1; BIOLOGICAL MARKER; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 1; GLUTATHIONE TRANSFERASE P1; KERATIN; LIPOCORTIN 5; LIVER PROTEIN; NUCLEAR PROTEIN; PROTEIN ACTB; PROTEOME; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DATA MINING; DISEASE COURSE; GEL ELECTROPHORESIS; HEPATITIS B; HISTOPATHOLOGY; LIVER CYTOSOL; LIVER FIBROSIS; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOSOL; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

ANIMALS; BIOLOGICAL MARKERS; CELL NUCLEUS; CYTOSOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPATITIS B; KERATINS; LIVER; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEOME; SUPEROXIDE DISMUTASE;

EID: 51649092791     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr7006522     Document Type: Article

References (63)

1. Friedman, S. L. Liver fibrosis sbdfrom bench to bedside. J. Hepatol. 2003, 38 (Suppl. 1), S38-S53.
2. Poynard, T.; Ratziu, V.; Benhamou, Y.; Opolon, P.; Cacoub, P.; Bedossa, P. Natural history of HCV infection. Baillieres Best Pract. Res. Clin. Gastroenterol. 2000, 14 (2), 211-228.
3. Gines, P.; Cardenas, A.; Arroyo, V.; Rodes, J. Management of cirrhosis and ascites. N. Engl. J. Med. 2004, 350, 1646-1654.
4. McKillop, I. H.; Moran, D. M.; Jin, X.; Koniaris, L. G. Molecular pathogenesis of hepatocellular carcinoma. J. Surg. Res. 2006, 136 (1), 125-135.
5. Higuchi, H.; Gores, G. J. Mechanisms of liver injury: an overview. Curr. Mol. Med. 2003, 3 (6), 483-490.
6. Iredale, J. P. Cirrhosis: new research provides a basis for rational and targeted treatments. Br. Med. J. 2003, 327, 143-147.
7. Afdhal, N. H.; Nunes, D. Evaluation of liver fibrosis: a concise review. Am. J. Gastroenterol. 2004, 99 (6), 1160-1174.
8. Thampanitchawong, P.; Piratvisuth, T. Liver biopsy: complications and risk factors. World J. Gastroenterol. 1999, 5 (4), 301-304.
9. Regev, A.; Berho, M.; Jeffers, L. J.; Minkowski, C.; Molina, E. G.; Pyrsopoulos, N. T.; Feng, Z. Z.; Reddy, K. R.; Schiff, E. R. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002, 97 (10), 2614-2618.
10. Tonge, R.; Shaw, J.; Middleton, B.; Rowlinson, R.; Rayner, S.; Young, J.; Pognan, F.; Hawkins, E.; Currie, I.; Davison, M. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1 (3), 377-396.
11. Chisari, F. V; Klopchin, K.; Moriyama, T.; Pasquinelli, C.; Dunsford, H. A.; Sell, S.; Pinkert, C. A.; Brinster, R. L.; Palmiter, R. D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989, 59 (6), 1145-1156.
12. Constandinou, C.; Henderson, N.; Iredale, J. P. Modelling liver fibrosis in rodents. Methods Mol. Med. 2005, 117, 237-250.
13. Tsukamoto, H.; Matsuoka, M.; French, S. W. Experimental models of hepatic fibrosis: a review. Semin. Liver Dis. 1990, 10, 56-65.
14. Chisari, F. V.; Pinkert, C. A.; Milich, D. R.; Filippi, P.; McLachlan, A.; Palmiter, R. D.; Brinster, R. L. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985, 230 (4730), 1157-1160.
15. Chisari, F. V.; Filippi, P.; Buras, J.; McLachlan, A.; Popper, H.; Pinkert, C. A.; Palmiter, R. D.; Brinster, R. L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 6909-6913.
16. Dunsford, H. A.; Sell, S.; Chisari, F. V. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res. 1990, 50, 3400-3407.
17. Toshkov, I.; Chisari, F. V.; Bannasch, P. Hepatic preneoplasia in hepatitis virus transgenic mice. Hepatology 1994, 20, 1162-1172.
18. Huang, S. N.; Chisari, F. V. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995, 21, 620-626.
19. Dathan, N.; Parlato, R.; Rosica, A.; De Felice, M.; Di Lauro, R. Distribution of the titf2/foxel gene product is consistent with an important role in the development of foregut endoderm, palate, and hair. Dev. Dyn. 2002, 224 (4), 450-456.
20. Ishak, K.; Baptista, A.; Bianchi, L.; Callea, F.; De Groote, J.; Gudat, F.; Denk, H.; Desmet, V.; Korb, G.; MacSween, R. N.; et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995, 22 (6), 696-699.
21. Cimmino, F.; Spano, D.; Capasso, M.; Zambrano, N.; Russo, R.; Zollo, M.; Iolascon, A. Comparative Proteomic Expression Profile in All-trans Retinoic Acid Differentiated Neuroblastoma Cell Line. J. Proteome Res. 2007, 6 (7), 2550-2564.
22. Dennis, G., Jr.; Sherman, B. T.; Hosack, D. A.; Yang, J.; Gao, W.; Lane, H. C.; Lempicki, R. A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. GenomeBiology 2003, 4 (5), P3.
23. Poon, T. C.; Hui, A. Y.; Chan, H. L.; Ang, I. L.; Chow, S. M.; Wong, N.; Sung, J. J. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin. Chem. 2005, 51 (2), 328-335.
24. Göbel, T.; Vorderwülbecke, S.; Hauck, K.; Fey, H.; Haussinger, D.; Erhardt, A. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J. Gastroenterol. 2006, 12 (47), 7604-7612.
25. Xu, X. Q.; Leow, C. K.; Lu, X.; Zhang, X.;.; Liu, J. S.; Wong, W. H.; Asperger, A.; Deininger, S.; Eastwood Leung, H. C. Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics. Proteomics 2004, 4 (10), 3235-3245.
26. Low, T. Y.; Leow, C. K.; Salto-Tellez, M.; Chung, M. C. A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004, 4 (12), 3960-3974.
27. Henkel, C.; Roderfeld, M.; Weiskirchen, R.; Berres, M. L.; Hill-ebrandt, S.; Lammert, F.; Meyer, H. E.; Stuhler, K.; Graf, J.; Roeb, E. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 2006, 6 (24), 6538-6548.
28. Do, S. H.; Yun, H. S.; Jeong, W. I.; Jeong, D. H.; Ki, M. R.; Chung, J. Y.; Park, S. J.; Kim, S. B.; Jeong, K. S. Up-regulation of Metabotropic glutamate receptor 3 (mGluR3) in rat fibrosis and cirrhosis model of persistent hypoxic condition. Mol. Cell. Biochem. 2007, 294 (1-2), 189-196.
29. Lindquist, S.; Craig, E. A. The heat-shock proteins. Annu. Rev. Genet. 1988, 22, 631-677.
30. Little, E.; Ramakrishnan, M.; Roy, B.; Gazit, G.; Lee, A. S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryotic Gene Expression 1994, 4, 1-18.
31. Garrido, C.; Gurbuxani, S.; Ravagnan, L.; Kroemer, G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 2001, 286, 433-442.
32. Srivastava, P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2002, 2, 185-194.
33. Srivastava, P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 2002, 20, 395-425.
34. Lim, S. O.; Park, S. G.; Yoo, J. H.; Park, Y. M.; Kim, H. J.; Jang, K. T.; Cho, J. W.; Yoo, B. C.; Jung, G. H.; Park, C. K. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World I Gastroenterol. 2005, 11 (14), 2072-2079.
35. Zhu, X. D.; Li, C. L.; Lang, Z. W.; Gao, G. F.; Tien, P. Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases. World J. Gastroenterol. 2004, 10 (8), 1141-1145.
36. Yao, D. F.; Wu, X. H.; Su, X. Q.; Yao, M.; Wu, W.; Qiu, L. W.; Zou, L.; Meng, X. Y. Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 2006, 5 (3), 381-386.
37. Toivola, D. M.; Ku, N. O.; Resurreccion, E. Z.; Nelson, D. R.; Wright, T. L.; Omary, M. B. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004, 40 (2), 459-466.
38. Strnad, P.; Lienau, T. C.; Tao, G. Z.; Lazzeroni, L. C.; Stickel, F.; Schuppan, D.; Omary, M. B. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology 2006, 43 (6), 1354-1363.
39. Fukaya, Y.; Yamaguchi, M. Regucalcin increases superoxide dis-mutase activity in rat liver cytosol. Biol. Pharm. Bull. 2004, 27 (9), 1444-1446.
40. Sitia, G.; Iannacone, M.; Müller, S.; Bianchi, M. E.; Guidotti, L. G. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukocyte Biol. 2007, 81 (1), 100-107.
41. Mannervick, B.; Alin, P.; Guthenberg, C.; Jensson, H.; Tahir, M. K.; Warholm, M.; Jornvall, H. Identification of three classes of cytosolic glutathione transferase enzymatic properties. Proc. Natl. Acad. Sci. U.S.A 1985, 82, 7202-7206.
42. Whalen, R.; Boyer, T. D. Human glutathione S-transferases. Semin. Liver Dis. 1998, 18 (4), 345-358.
43. Coles, B.; Ketterer, B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 1990, 25, 47-70.
44. Tsuchida, S.; Sato, K. Glutathione transferases and cancer. Crit. Rev. Biochem. Mol. Biol. 1992, 27, 337-384.
45. Rushmore, T. H.; Pichett, C. B. Glautathione S-transferases. Supergene family: regulation, and therapeutic implications. J. Biol. Chem. 1993, 268, 11475-11478.
46. Hayes, J. D.; Pulford, D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30, 445-600.
47. Mohammadzadeh Ghobadloo, S.; Yaghmaei, B.; Allameh, A.; Hassani, P.; Noorinayer, B.; Zali, M. R. Polymorphisms of glutathione S-transferase Ml, Tl, and PI in patients with HBV-related liver cirrhosis, chronic hepatitis, and normal carriers. Clin. Biochem. 2006, 39 (1), 46-49.
48. Yu, M. W.; Yang, S. Y.; Pan, I. J.; Lin, C. L.; Liu, C. J.; Liaw, Y. F.; Lin, S. M.; Chen, P. J.; Lee, S. D.; Chen, C. J. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 2003, 95 (19), 1485-1488.
49. Van Greevenbroek, M. M.; Vermeulen, V. M.; De Bruin, T. W. Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19. J. Lipid Res. 2004, 45 (6), 1148-1154.
50. Douette, P.; Navet, R.; Gerkens, P.; de Pauw, E.; Leprince, P.; Sluse-Goffart, C.; Sluse, F. E. Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4 (6), 2024-2031.
51. Siegers, C. P.; Bossen, K. H.; Younes, M.; Mahlke, R.; Oltmanns, D. Glutathione and glutathione-S-transferases in the normal and diseased human liver. Pharmacol. Res. Commun. 1982, 14 (1), 61-72.
52. Burim, R. V.; Canalle, R.; Martinelli Ade, L.; Takahashi, C. S. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 2004, 19 (4), 291-298.
53. Ghobadloo, S. M.; Yaghmaei, B.; Bakayev, V.; Goudarzi, H.; Noorinayer, B.; Rad, F. H.; Samiy, S.; Aghabozorghi, S.; Zali, M. R. GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis. J. Gastrointest. Surg. 2004, 8 (4), 423-427.
54. Lee, H. C.; Lee, H. S.; Jung, S. H.; Yi, S. Y.; Jung, H. K.; Yoon, J. H.; Kim, C. Y. Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J. Korean Med. Sci. 2001, 16 (6), 745-750.
55. Cichoz-Lach, H.; Partycka, J.; Nesina, I.; Celinski, K.; Slomka, M.; Wojcierowski, J. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphism in alcohol liver cirrhosis and alcohol chronic pancreatitis among Polish individuals. Scand. J. Gastroenterol. 2007, 42 (4), 493-498.
56. Mori, T.; Nagai, K.; Mori, M.; Nagao, M.; Imamura, M.; Iijima, M.; Kobayashi, K. Progressive liver fibrosis in late-onset argininosuc-cinate lyase deficiency. Pediatr. Dev. Pathol. 2002, 5 (6), 597-601.
57. Bergeron, A.; D'Astous, M.; Timm, D. E.; Tanguay, R. M. Structural and functional analysis of missense mutations in fumarylacetoac-etate hydrolase, the gene deficient in hereditary tyrosinemia type 1. J. Biol. Chem. 2001, 276 (18), 15225-15231.
58. Taketa, K.; Shimamura, J.; Takesue, A.; Tanaka, A.; Kosaka, K. Undifferentiated patterns of key carbohydrate-metabolizing enzymes in injured livers. II. Human viral hepatitis and cirrhosis of the liver. Enzyme 1976, 21 (3), 200-210.
59. Sutton, A.; Nahon, P.; Pessayre, D.; Rufat, P.; Poire, A.; Ziol, M.; Vidaud, D.; Barget, N.; Ganne-Carrie, N.; Charnaux, N.; Trinchet, J. C.; Gattegno, L.; Beaugrand, M. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res. 2006, 66 (5), 2844-2852.
60. Seckin, Y.; Harputluoglu, M. M.; Batcioglu, K.; Karincaoglu, M.; Yildirim, B.; Oner, R. I.; Uyumlu, B.; Aydogdu, N.; Hilmioglu, F. Gastric tissue oxidative changes in portal hypertension and cirrhosis. Dig. Dis. Sci. 2007, 52 (5), 1154-1158.
61. Czeczot, H.; Scibior, D.; Skrzycki, M.; Podsiad, M. Activity of antioxidant enzymes in patients with liver cirrhosis. Wiad. Lek. 2006, 59 (11-12), 762-766.
62. Spitsyn, V. A.; Nafikova, A. Kh.; Spitsyna, N. Kh.; Afanas'eva, I. S. Genetic predisposition to development of toxic liver cirrhosis caused by alcohol. Genetika 2001, 37 (5), 698-707.
63. Yamaguchi, M.; Isogai, M.; Shimada, N. Potential sensitivity of hepatic specific protein regucalcin as a marker of chronic liver injury. Mol. Cell. Biochem. 1997, 167 (l-2), 187-190.